CD63 Antibody from SICGEN ANTIBODIES

Search, find, compare suppliers for anti-CD63 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD63
Clonepolyclonal
Host SpeciesGoat
Reactive Specieshuman, mouse, rat, bovine, canine, chicken/avian, donkey, feline, goat, guinea pig, hamster, horse, porcine, rabbit, sheep, simian
Isotypen/a
Formatepitope affinity purified
Size1.5 mg
Concentration3 mg/ml
ApplicationsWB, IF, IHC-P, IHC-F
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRRID: AB_2333130. CD63 is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of the members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. These proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker. Reacts with CD63, a 40-60 kDa glycoprotein, detected by Western blot in the following human (HeLa, HUH, Jurkat), mouse (AtT-20, Hepa, 3T3, RAW264.7), canine (MDCK) and monkey (COS-7) whole cell lysates.
ImmunogenPurified recombinant peptide derived from within residues 120 aa to 175 aa of human CD63 produced in E. coli.
Other NamesCD63 antigen, CD63 antigen (melanoma 1 antigen), granulophysin, LAMP-3, lysosomal-associated membrane protein 3, lysosome-associated membrane glycoprotein 3, ME491, melanoma-associated antigen, melanoma 1 antigen, melanoma-associated antigen ME491, MLA1, ocular melanoma-associated antigen, OMA81H, tetraspanin-30, TSPAN30 antibody.
Gene, Accession #Accession: ENSG00000135404
Catalog #AB0047-500
Price450 €
Order / More InfoCD63 Antibody from SICGEN ANTIBODIES
Product Specific References1. Amorim M, Martins B, Caramelo F, et al. Front Med (Lausanne) 2022 May. PMID: 35692536 2. Matsui T, Sakamaki Y, Nakashima S, et al. Cell Rep 2022 May. PMID: 35649370 3. Martins-Marques T, Costa MC, Catarino S, et al. EMBO Rep 2022 May. PMID: 35593040 4. Ferreira JV, Soares AR, Ramalho J, et al. Sci Adv 2022 Mar. PMID: 35333565 5. Saludas L, Garbayo E, Ruiz-Villalba A, et al. Eur J Pharm Biopharm 2021 Dec. PMID: 34968647 6. Garbayo E, Ruiz-Villalba A, Hernandez SC, et al. Acta Biomater 2021 May. PMID: 33716175 7. Aires ID, Ribeiro-Rodrigues T, Boia R, et al. Glia 2020 Dec. PMID: 32645245 8. Martins-Marques T, Ribeiro-Rodrigues T, de Jager SC, et al. Life Sci Alliance 2020 Oct. PMID: 33097557 9. Armando F, Gambini M, Corradi A, et al. Viruses 2020 Feb. PMID: 32054075 10. Simpong LD, PhD Thesis Universitat Leipzig, Germany 2020 11. Carvalho AS, Moraes MCS, Hyun Na C, et al. Cancers 2020 Nov. PMID: 33233545 12. Ferreira JV, Rosa Soares A, Ramalho JS, et al. PLoS One 2019 Oct. PMID:31613922 13. Cardoso MHS, PhD Thesis, NOVA University of Lisbon, Portugal 2018 14. Martins-Marques T, Pinho MJ, Zuzarte M. et al. J Extracell Vesicles 2016 Sep 29;5:32538. PMID:27702427 15. Successfully validated (Western Blotting) by Center for Diabetes and Metabolic Diseases, Indiana University, US
SICGEN ANTIBODIES
SICGEN ANTIBODIES
SICGEN ANTIBODIES
Research and Development in Biotechnology Ltd
BIOCANT PARK Nucleo 04, Lt 03
3060-196 Cantanhede PORTUGAL
P: +351 91 9145219
F: +351 21 458 21 89

information@sicgen.pt
Technical Support: technical@sicgen.pt

http://www.sicgen.pt

Profile of SICGEN ANTIBODIES
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.